Breaking News Instant updates and real-time market news.

CCIV

Churchill Capital Corp IV

$23.18 /

+0.23 (+1.00%)

, LCID

Lucid Group

/

+

11:18
07/23/21
07/23
11:18
07/23/21
11:18

Churchill Capital Corp IV, Lucid Motors close business combination

Churchill Capital Corp IV (CCIV) and Lucid Motors announced the completion of their business combination. Churchill IV, whose shares of common stock, warrants and units are currently listed on the New York Stock Exchange, will delist from the NYSE. Shares of common stock and warrants of the post-combination company, renamed Lucid Group, will be listed on The Nasdaq Stock Market beginning on July 26, 2021 under the ticker symbols "LCID" and "LCIDW," respectively. Units will no longer trade separately. As previously announced, Peter Rawlinson will continue to lead Lucid along with the rest of the company's seasoned leadership team. Churchill IV's leadership team and group of operating partners will actively facilitate key introductions and relationships and provide product, design and industry insights.

CCIV

Churchill Capital Corp IV

$23.18 /

+0.23 (+1.00%)

LCID

Lucid Group

/

+

CCIV Churchill Capital Corp IV
$23.18 /

+0.23 (+1.00%)

05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
02/23/21 Wells Fargo
Trinity Capital initiated with an Overweight at Wells Fargo
LCID Lucid Group
/

+

TODAY'S FREE FLY STORIES

Recommendations
Citi survey shows Nike 'back in favor' with Chinese consumer » 06:35
09/21/21
09/21
06:35
09/21/21
06:35
NKE

Nike

$154.23 /

-2.25 (-1.44%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

09/20/21 Deutsche Bank
Nike price target lowered to $171 from $179 at Deutsche Bank
09/20/21 Piper Sandler
Nike supply chain disruptions creates buying opportunity, says Piper Sandler
09/13/21
Fly Intel: Top five analyst downgrades
09/13/21 BTIG
BTIG downgrades Nike on 'severe supply chain disruptions' in Vietnam
NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

Recommendations
Axalta Coating price target lowered to $36 from $38 at RBC Capital » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
AXTA

Axalta Coating

$27.96 /

-0.61 (-2.14%)

RBC Capital analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

09/15/21 BofA
Axalta Coating removed from US 1 List at BofA
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
07/28/21 Deutsche Bank
Axalta Coating price target lowered to $36 from $38 at Deutsche Bank
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

Hot Stocks
Aerie Pharmaceuticals says Vicente Anido, PhD no longer serving as CEO » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
AERI

Aerie Pharmaceuticals

$11.59 /

-1.27 (-9.88%)

Aerie Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

Initiation
Citi Trends initiated with a Buy at Benchmark » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
CTRN

Citi Trends

$70.61 /

+0.5 (+0.71%)

Benchmark analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

08/25/21 Craig-Hallum
Citi Trends price target raised to $165 from $150 at Craig-Hallum
05/26/21 Craig-Hallum
Citi Trends price target raised to $150 from $142 at Craig-Hallum
04/15/21 Craig-Hallum
Citi Trends price target raised to $142 from $125 at Craig-Hallum
03/17/21 Craig-Hallum
Citi Trends price target raised to $125 from $93 at Craig-Hallum
CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

Earnings
Apogee Enterprises sees FY22 adjusted EPS $2.20-$2.40, consensus $2.28 » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
APOG

Apogee Enterprises

$39.34 /

-1.09 (-2.70%)

The company previously…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

06/28/21 Craig-Hallum
Apogee Enterprises price target raised to $48 from $43 at Craig-Hallum
04/09/21 DA Davidson
Apogee Enterprises price target raised to $33 from $28 at DA Davidson
12/21/20 Craig-Hallum
Apogee Enterprises price target raised to $39 from $31 at Craig-Hallum
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

Hot Stocks
Activision Blizzard says working with regulators to address workplace complaints » 06:33
09/21/21
09/21
06:33
09/21/21
06:33
ATVI

Activision Blizzard

$76.20 /

-3.415 (-4.29%)

, DIS

Disney

$178.63 /

-4.865 (-2.65%)

Activision Blizzard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
DIS Disney
$178.63 /

-4.865 (-2.65%)

05:19 Today Daiwa
Disney initiated with a Buy at Daiwa
09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/09/21 Arete
Disney initiated with a Buy at Arete
ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

Hot Stocks
Verso enters confidentiality agreement with Atlas Holdings » 06:32
09/21/21
09/21
06:32
09/21/21
06:32
VRS

Verso

$19.38 /

-0.13 (-0.67%)

Verso announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRS Verso
$19.38 /

-0.13 (-0.67%)

VRS Verso
$19.38 /

-0.13 (-0.67%)

08/09/21 B. Riley
Verso downgraded to Neutral on valuation at B. Riley
08/09/21 B. Riley
Verso downgraded to Neutral from Buy at B. Riley
07/13/21 BWS Financial
Atlas proposal 'materially undervalues' Verso, says BWS Financial
05/10/21 BWS Financial
Verso price target raised to $30 from $25.50 at BWS Financial
Earnings
Apogee Enterprises reports Q2 adjusted EPS 53c, consensus 55c » 06:31
09/21/21
09/21
06:31
09/21/21
06:31
APOG

Apogee Enterprises

$39.34 /

-1.09 (-2.70%)

Reports Q2 revenue $326M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

06/28/21 Craig-Hallum
Apogee Enterprises price target raised to $48 from $43 at Craig-Hallum
04/09/21 DA Davidson
Apogee Enterprises price target raised to $33 from $28 at DA Davidson
12/21/20 Craig-Hallum
Apogee Enterprises price target raised to $39 from $31 at Craig-Hallum
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

Upgrade
Jefferies upgrades Steven Madden to Buy on 'best-in-class' supply chain » 06:30
09/21/21
09/21
06:30
09/21/21
06:30
SHOO

Steven Madden

$39.18 /

-0.49 (-1.24%)

Jefferies analyst Janine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

04:43 Today Jefferies
Steven Madden upgraded to Buy from Hold at Jefferies
09/17/21 BTIG
Steven Madden price target raised to $59 from $57 at BTIG
07/29/21 B. Riley
Steven Madden price target raised to $51 from $50 at B. Riley
07/29/21 Piper Sandler
Steven Madden price target raised to $45 from $39 at Piper Sandler
SHOO Steven Madden
$39.18 /

-0.49 (-1.24%)

Downgrade
Zumiez downgraded to Hold on slowing skate cycle at Jefferies » 06:27
09/21/21
09/21
06:27
09/21/21
06:27
ZUMZ

Zumiez

$40.89 /

-1.75 (-4.10%)

Jefferies analyst Janine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

04:44 Today Jefferies
Zumiez downgraded to Hold from Buy at Jefferies
09/13/21 B. Riley
Zumiez price target lowered to $56 from $65 at B. Riley
09/10/21 Baird
Zumiez price target lowered to $47 from $52 at Baird
09/08/21 Pivotal Research
Zumiez price target lowered to $45 from $52 at Pivotal Research
ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

ZUMZ Zumiez
$40.89 /

-1.75 (-4.10%)

Initiation
Univar initiated with a Buy at UBS » 06:24
09/21/21
09/21
06:24
09/21/21
06:24
UNVR

Univar

$22.07 /

-0.42 (-1.87%)

UBS analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNVR Univar
$22.07 /

-0.42 (-1.87%)

UNVR Univar
$22.07 /

-0.42 (-1.87%)

08/25/21
Fly Intel: Top five analyst upgrades
08/25/21 Berenberg
Univar upgraded to Buy from Hold at Berenberg
05/11/21 Wells Fargo
Univar price target raised to $27 from $19 at Wells Fargo
05/11/21 Barclays
Univar price target raised to $28 from $22 at Barclays
UNVR Univar
$22.07 /

-0.42 (-1.87%)

UNVR Univar
$22.07 /

-0.42 (-1.87%)

UNVR Univar
$22.07 /

-0.42 (-1.87%)

Initiation
FinVolution initiated with Buy, $9.20 target at China Renaissance » 06:22
09/21/21
09/21
06:22
09/21/21
06:22
FINV

FinVolution Group

$5.55 /

-0.255 (-4.39%)

China Renaissance analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

04:50 Today China Renaissance
FinVolution Group initiated with a Buy at China Renaissance
08/24/21 Citi
FinVolution Group downgraded to Neutral from Buy at Citi
03/12/21 Citi
FinVolution Group upgraded to Buy from Neutral at Citi
FINV FinVolution Group
$5.55 /

-0.255 (-4.39%)

Initiation
Bechtle initiated with a Buy at UBS » 06:19
09/21/21
09/21
06:19
09/21/21
06:19
BECTY

Bechtle

$14.83 /

+ (+0.00%)

UBS analyst Jad Younes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BECTY Bechtle
$14.83 /

+ (+0.00%)

08/19/21 Berenberg
Bechtle price target lowered to EUR 58 from EUR 175 at Berenberg
02/09/21 Berenberg
Bechtle price target raised to EUR 175 from EUR 166 at Berenberg
10/28/20 Kepler Cheuvreux
Bechtle upgraded to Buy from Hold at Kepler Cheuvreux
Syndicate
Blue Apron files registration statement for previously announced rights offering » 06:18
09/21/21
09/21
06:18
09/21/21
06:18
APRN

Blue Apron

$4.72 /

-0.32 (-6.35%)

Blue Apron filed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

10/30/20 Canaccord
Blue Apron price target lowered to $14 from $18 at Canaccord
APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

  • 16
    Jun
APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

APRN Blue Apron
$4.72 /

-0.32 (-6.35%)

Hot Stocks
Infosys announces collaboration with ServiceNow » 06:18
09/21/21
09/21
06:18
09/21/21
06:18
INFY

Infosys

$22.77 /

-0.075 (-0.33%)

, NOW

ServiceNow

$648.65 /

-2.845 (-0.44%)

Infosys (INFY) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFY Infosys
$22.77 /

-0.075 (-0.33%)

NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

INFY Infosys
$22.77 /

-0.075 (-0.33%)

07/15/21 Susquehanna
Infosys price target raised to $22 from $21 at Susquehanna
04/15/21 Susquehanna
Infosys margin reversion due to wage inflation is temporary, says Susquehanna
04/14/21 Stifel
Infosys stock reaction may reflect valuation/sentiment into report, says Stifel
04/14/21 Baird
Infosys price target raised to $18 from $17 at Baird
NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

09/17/21 Barclays
ServiceNow price target raised to $784 from $667 at Barclays
08/19/21 Oppenheimer
ServiceNow assumed with an Outperform at Oppenheimer
07/29/21 BMO Capital
ServiceNow price target raised to $650 from $575 at BMO Capital
07/29/21 KeyBanc
ServiceNow price target raised to $718 from $660 at KeyBanc
INFY Infosys
$22.77 /

-0.075 (-0.33%)

NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

INFY Infosys
$22.77 /

-0.075 (-0.33%)

NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

NOW ServiceNow
$648.65 /

-2.845 (-0.44%)

Initiation
Inhibrx initiated with an Outperform at JMP Securities » 06:18
09/21/21
09/21
06:18
09/21/21
06:18
INBX

Inhibrx

$35.76 /

-1.2 (-3.25%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INBX Inhibrx
$35.76 /

-1.2 (-3.25%)

INBX Inhibrx
$35.76 /

-1.2 (-3.25%)

04/26/21 Credit Suisse
Inhibrx assumed with an Outperform at Credit Suisse
02/03/21 Credit Suisse
Inhibrx price target raised to $44 from $28 at Credit Suisse
INBX Inhibrx
$35.76 /

-1.2 (-3.25%)

Recommendations
Merck faces 'compelling series' of catalysts into 2022, says Barclays » 06:15
09/21/21
09/21
06:15
09/21/21
06:15
MRK

Merck

$71.91 /

+0.21 (+0.29%)

Looking to the end of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades Merck to Equal Weight, awaits strategic action
09/07/21 Morgan Stanley
Merck downgraded to Equal Weight from Overweight at Morgan Stanley
MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

Initiation
eFfector Therapeutics initiated with an Outperform at JMP Securities » 06:15
09/21/21
09/21
06:15
09/21/21
06:15
EFTR

eFfector Therapeutics

$18.05 /

-1.49 (-7.63%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EFTR eFfector Therapeutics
$18.05 /

-1.49 (-7.63%)

EFTR eFfector Therapeutics
$18.05 /

-1.49 (-7.63%)

09/20/21 Stifel
eFfector Therapeutics initiated with a Hold at Stifel
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Cantor Fitzgerald
eFfector Therapeutics initiated with an Overweight at Cantor Fitzgerald
09/13/21 Cantor Fitzgerald
eFfector Therapeutics initiated with an Overweight at Cantor Fitzgerald
Upgrade
Warner Music upgraded to Outperform on streaming growth at Credit Suisse » 06:12
09/21/21
09/21
06:12
09/21/21
06:12
WMG

Warner Music

$40.26 /

-1.14 (-2.75%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMG Warner Music
$40.26 /

-1.14 (-2.75%)

WMG Warner Music
$40.26 /

-1.14 (-2.75%)

06:07 Today Credit Suisse
Warner Music upgraded to Outperform from Neutral at Credit Suisse
08/17/21 Tigress Financial
Warner Music price target raised to $48 from $42 at Tigress Financial
04/22/21 Jefferies
Warner Music initiated with a Hold at Jefferies
03/18/21 Redburn
Redburn sees 40% downside in Warner Music, starts with Sell rating
WMG Warner Music
$40.26 /

-1.14 (-2.75%)

  • 09
    Sep
  • 09
    Dec
WMG Warner Music
$40.26 /

-1.14 (-2.75%)

WMG Warner Music
$40.26 /

-1.14 (-2.75%)

Hot Stocks
Clean Energy to supply World Fuel Services with 78M gallons of LNG » 06:12
09/21/21
09/21
06:12
09/21/21
06:12
CLNE

Clean Energy

$7.58 /

-0.485 (-6.01%)

Clean Energy Fuels…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLNE Clean Energy
$7.58 /

-0.485 (-6.01%)

CLNE Clean Energy
$7.58 /

-0.485 (-6.01%)

07/14/21 Evercore ISI
Clean Energy initiated with an Underperform at Evercore ISI
05/11/21 Needham
Clean Energy initiated with a Buy at Needham
05/10/21 Needham
Clean Energy initiated with a Buy at Needham
04/22/21 Credit Suisse
Clean Energy bears missing elements of Amazon deal, says Credit Suisse
CLNE Clean Energy
$7.58 /

-0.485 (-6.01%)

CLNE Clean Energy
$7.58 /

-0.485 (-6.01%)

CLNE Clean Energy
$7.58 /

-0.485 (-6.01%)

Periodicals
Apple working on iPhone technology to help detect depression, WSJ reports » 06:12
09/21/21
09/21
06:12
09/21/21
06:12
AAPL

Apple

$143.02 /

-2.98 (-2.04%)

, BIIB

Biogen

$298.53 /

-1.45 (-0.48%)

Apple (AAPL) is working…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$143.02 /

-2.98 (-2.04%)

BIIB Biogen
$298.53 /

-1.45 (-0.48%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

09/17/21 Jefferies
Snap Q3 revenue estimates too low, says Jefferies
09/15/21 Oppenheimer
Apple's iPhone 13 likely to attract upgraders, says Oppenheimer
09/15/21 Deutsche Bank
Apple iPhone changes 'more incremental than transformative,' says Deutsche Bank
09/15/21 Morgan Stanley
Improved iPhone affordability raises Morgan Stanley confidence in Apple growth
BIIB Biogen
$298.53 /

-1.45 (-0.48%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/20/21 Piper Sandler
Neurologist survey shows Aduhelm 'rebounded sharply,' says Piper Sandler
09/16/21 UBS
Biogen price target lowered to $442 from $475 at UBS
09/15/21 BofA
Biogen price target lowered to $360 from $400 at BofA
AAPL Apple
$143.02 /

-2.98 (-2.04%)

BIIB Biogen
$298.53 /

-1.45 (-0.48%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

BIIB Biogen
$298.53 /

-1.45 (-0.48%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

BIIB Biogen
$298.53 /

-1.45 (-0.48%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

BIIB Biogen
$298.53 /

-1.45 (-0.48%)

AAPL Apple
$143.02 /

-2.98 (-2.04%)

Initiation
Atlanticus Holdings initiated with an Outperform at JMP Securities » 06:11
09/21/21
09/21
06:11
09/21/21
06:11
ATLC

Atlanticus Holdings

$48.46 /

-1.085 (-2.19%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATLC Atlanticus Holdings
$48.46 /

-1.085 (-2.19%)

ATLC Atlanticus Holdings
$48.46 /

-1.085 (-2.19%)

08/17/21 B. Riley
Atlanticus Holdings price target raised to $63 from $60 at B. Riley
06/14/21 B. Riley
B. Riley starts Atlanticus at Buy, sees valuation discount narrowing
06/14/21 B. Riley
Atlanticus Holdings initiated with a Buy at B. Riley
ATLC Atlanticus Holdings
$48.46 /

-1.085 (-2.19%)

Recommendations
Clovis price target lowered to $9 from $10 at H.C. Wainwright » 06:09
09/21/21
09/21
06:09
09/21/21
06:09
CLVS

Clovis

$4.56 /

-0.28 (-5.79%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLVS Clovis
$4.56 /

-0.28 (-5.79%)

CLVS Clovis
$4.56 /

-0.28 (-5.79%)

08/05/21 H.C. Wainwright
Clovis price target lowered to $10 from $12 at H.C. Wainwright
06/07/21 Piper Sandler
Clovis reported 'underwhelming datasets' at ASCO, says Piper Sandler
03/19/21 Goldman Sachs
Goldman says Clovis reaction 'disproportionate' for already disclosed data
02/23/21 H.C. Wainwright
Clovis price target lowered to $13 from $15 at H.C. Wainwright
CLVS Clovis
$4.56 /

-0.28 (-5.79%)

CLVS Clovis
$4.56 /

-0.28 (-5.79%)

CLVS Clovis
$4.56 /

-0.28 (-5.79%)

Initiation
Recursion Pharmaceuticals initiated with a Buy at Berenberg » 06:09
09/21/21
09/21
06:09
09/21/21
06:09
RXRX

Recursion Pharmaceuticals

$26.10 /

-0.74 (-2.76%)

Berenberg analyst Gal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RXRX Recursion Pharmaceuticals
$26.10 /

-0.74 (-2.76%)

RXRX Recursion Pharmaceuticals
$26.10 /

-0.74 (-2.76%)

05/11/21
Fly Intel: Top five analyst initiations
05/11/21 SVB Leerink
SVB Leerink bullish on Recursion Pharmaceuticals, initiates with an Outperform
05/11/21 BofA
BofA starts Recursion Pharmaceuticals at Buy with $31 price target
05/11/21 SVB Leerink
Recursion Pharmaceuticals initiated with an Outperform at SVB Leerink
RXRX Recursion Pharmaceuticals
$26.10 /

-0.74 (-2.76%)

  • 16
    Apr
RXRX Recursion Pharmaceuticals
$26.10 /

-0.74 (-2.76%)

RXRX Recursion Pharmaceuticals
$26.10 /

-0.74 (-2.76%)

Earnings
Great Elm Group reports Q4 cont ops EPS (6c), one estimate 9c » 06:09
09/21/21
09/21
06:09
09/21/21
06:09
GEG

Great Elm Group

$2.35 /

-0.12 (-4.86%)

Reports Q4 revenue 16.3M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GEG Great Elm Group
$2.35 /

-0.12 (-4.86%)

GEG Great Elm Group
$2.35 /

-0.12 (-4.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.